Sign in

CIK 0001919246

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Pelthos Therapeutics Inc.

Sign in to watch
Ticker
PTHS
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
863335449
Phone
+1 919-908-2422
Business address
4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
Former names
Channel Therapeutics Corp, Chromocell Therapeutics Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$44,939
in 3 filings, $45K under 10b5-1 plans

Net −$44,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-04-02 Malamut Richard Director Sale 10b5-1 −310 $20.51 $6K 27,702
2026-04-02 Malamut Richard Director Sale 10b5-1 −280 $21.36 $6K 27,422
2025-11-13 Malamut Richard Director Grant or award +2,454 8,904
2025-07-02 Malamut Richard Director Grant or award +19,108 28,012
2025-07-02 Malamut Richard Director Grant or award · Restricted Stock Units +19,108 28,012
2025-07-02 Malamut Richard Director Grant or award · Stock Option +58,230 58,230
2024-11-13 Malamut Richard Director Grant or award · Restricted Stock Units +24,533 116,098
2024-09-12 Malamut Richard Director Purchase +10,400 $0.94 $10K 91,565
2024-06-14 Malamut Richard Director Grant or award +6,450 6,450
2024-06-14 Malamut Richard Director Grant or award · Restricted Stock Units +64,498 81,165

Page 1 of 1 · 10 trades